Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Assets Average (2016 - 2025)

Plus Therapeutics has reported Assets Average over the past 15 years, most recently at $17.5 million for Q4 2025.

  • Quarterly Assets Average rose 157.11% to $17.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.5 million through Dec 2025, up 157.11% year-over-year, with the annual reading at $11.5 million for FY2025, 27.4% up from the prior year.
  • Assets Average was $17.5 million for Q4 2025 at Plus Therapeutics, up from $14.5 million in the prior quarter.
  • Over five years, Assets Average peaked at $23.5 million in Q4 2022 and troughed at $6.8 million in Q4 2024.
  • The 5-year median for Assets Average is $15.1 million (2021), against an average of $15.9 million.
  • Year-over-year, Assets Average crashed 56.94% in 2024 and then skyrocketed 157.11% in 2025.
  • A 5-year view of Assets Average shows it stood at $23.4 million in 2021, then grew by 0.51% to $23.5 million in 2022, then plummeted by 47.49% to $12.3 million in 2023, then plummeted by 44.82% to $6.8 million in 2024, then surged by 157.11% to $17.5 million in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Assets Average are $17.5 million (Q4 2025), $14.5 million (Q3 2025), and $11.2 million (Q2 2025).